Prevalence of neural tube defects in the province of Quebec, 1992

Canadian Journal of Public Health

Volumn 90, Issue 4, 1999, Pages 237-239

  De Wals, Philippe ^a,b   Trochet, Cécile ^c   Pinsonneault, Linda ^c  

^a IL   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; FOLIC ACID;

ABORTION; ARTICLE; CANADA; FETUS ECHOGRAPHY; HEALTH CARE POLICY; HUMAN; NEURAL TUBE DEFECT; NEWBORN; PRENATAL DIAGNOSIS; VITAMIN SUPPLEMENTATION;

EID: 0032780099     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404123     Document Type: Article

References (24)

1. Elwood JM, Little J, Elwood JH. Epidemiology and Control of Neural Tube Defects. New York: Oxford University Press, 1992.
2. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-45.
3. Bower C, Stanley FJ. Dietary folate as a risk factor for neural tube defects: Evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-19.
4. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-52.
5. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council vitamin study. Lancet 1991;338:131-37.
6. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-35.
7. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.
8. Shaw GM, Schaffer D, Velie EM, et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:9-26.
9. SOGC Genetics Committee. Recommendations on the use of folic acid for the prevention of neural tube defects. Journal SOGC 1993;March supplement:41-46.
10. Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. CMAJ 1994;151:159-66.
11. Department of Health and Human Services. Food and Drug Administration. Food standards: Amendments of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996;61:8781-97.
12. Society of Obstetricians and Gynaecologists of Canada. SOGC Clinical Practice Guidelines for Obstetrics, guidelines for the performance of ultrasound in obstetrics and gynaecology. Policy Statement, No.8, 1994.
13. Rouleau J, Arbuckle TE, Johnson KC, et al. Description and limitations of the Canadian Congenital Anomalies Surveillance System (CCASS). Chron Dis Can 1995;16:37-42.
14. International Classification of Diseases. 1975 Revision. Volumes 1 and 2. World Health Organization, Geneva, 1978.
15. Scherrer B (Ed.). Biostatistique. Montreal: Gaétan Morin, 1995; 356-789.
16. Horowitz I, McDonald AD. Anencephaly and spina bifida in the Province of Quebec. CMAJ 1969;100:748-55.
17. Hunter AGW. Neural tube defects in Eastern Ontario and Western Quebec: Demography and family data. Am J Med Genet 1984;19:45-63.
18. EUROCAT Working Group. EUROCAT Report 7. 15 years of surveillance of congenital anomalies in Europe 1980-1994. Brussels: Scientific Institute of Public Health-Louis Pasteur, 1997.
19. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis, 1985-1994. MMWR 1995;44,SS-4:1-13.
20. Johnson KC, Rouleau J. Temporal trends in Canada birth defects birth prevalences, 1979-1993. Can J Public Health 1997;88:169-76.
21. Santé Québec. Rapport de l'enquête québécoise sur la nutrition, 1990. Montréal: Ministère de la santé et des services sociaux, Gouvernement du Québec, 1995.
22. Hexter AC, Harris JA, Roeper P, et al. Evaluation of the Hospital Discharge Diagnoses Index and the birth certificate as sources of information on birth defects. Public Health Rep 1990;105:296-305.
23. Calle EE, Khoury MJ. Completeness of the discharge diagnoses as a measure of birth defects recorded in the hospital birth record. Am J Epidemiol 1991;134:69-77.
24. Callif-Daley FA, Huether CA, Edmonds LD. Evaluating false positives in two hospital discharge data sets of the Birth Defects Monitoring Program. Public Health Rep 1995;110:154-60.